Veterinary Compounding for Hyperadrenocorticism (Cushing's Disease) in Dogs
Download in electronic PDF format for $75
Abstract: This discussion covers the pathophysiologic factors of Cushing’s disease in dogs, signs and symptoms of canine Cushing’s disease (increased water consumption and urination, increased appetite, abdominal enlargement, alopecia and epidermal atrophy and other signs), diagnosis, treatment, monitoring and prognosis. A list of compounds potentially useful in the diagnosis and treatment is provided, along with a list of information helpful to permit importation of an unapproved drug and contact address for the relevant person to contact at the US Food and Drug Administration. The author concludes that compounding pharmacists can greatly contribute to the successful diagnosis, treatment and management of Cushing’s disease by providing products for diagnosis and treatment and by participating actively in patient follow-up during therapy. By fully understanding the pathophysiologic factors and natural history of the disorder, pharmacists can support both owners and veterinarians in the difficult process of managing dogs with this disorder.
Related Keywords:
Canine Cushing's disease, compounding for, Cushing's disease, canine, compounding for, Hyperadrenocorticism, canine, compounding for
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
The Treatment of Canine Atopic Disease
Davidson Gigi S
|
May/Jun 2002
Pg. 210-215
|
Treating Canine Hepatic Disease
Davidson Gigi S
|
May/Jun 2003
Pg. 188-191
|
Veterinary Compounding for Hyperadrenocorticism (Cushing's Disease) in Dogs
Davidson Gigi S
|
Sep/Oct 2002
Pg. 332-336
|
Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
|
Jul/Aug 2003
Pg. 288-291
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Equine Cushing’s Syndrome
Vail Jane
|
Jan/Feb 2003
Pg. 27-29
|
Equine Cushing's Disease: A Clinical Update
Bliss George
|
Sep/Oct 2007
Pg. 384-388
|
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Helms Scott R, Fox Samantha, Mixon William, Vail Jane
|
Jan/Feb 2012
Pg. 34-41
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
|
Jan/Feb 2014
Pg. 6-12
|
Calculations
Prince Shelly J
|
Sep/Oct 2002
Pg. 387
|
Basics of Compounding for Cold Sores or Fever Blisters
Allen Loyd V Jr
|
May/Jun 2004
Pg. 206-209
|
Canine Public Servants: Caring for Drug Detection Dogs
Davidson Gigi S
|
Sep/Oct 2008
Pg. 384-390
|
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy, Williams LaVonn
|
Jul/Aug 2022
Pg. 293-296
|
Navigating New Territories in Compounding for Veterinary Medicine
Davidson Gigi S
|
Sep/Oct 2002
Pg. 324-327
|
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2
Davidson Gigi S
|
Jul/Aug 2004
Pg. 277-283
|
Pergolide 500-mcg Capsules, Veterinary
Allen Loyd V Jr
|
May/Jun 2005
Pg. 231
|
Pergolide 0.2-mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
|
May/Jun 2005
Pg. 232
|
Canine Soft Chew Base (Veterinary)
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 143
|
Return to Top |